ADCTADC Therapeutics SABasingEarnings in 14 days

TodayBasingjumpy stock

NYSEDrug Manufacturers - Specialty & GenericMarket cap $192.78MReports Nov 10, 2026

ADC Therapeutics SA

Oncology
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Market cap
$192.78M
Employees
188
Exchange
NYSE
Country
Switzerland
1.51+4.86% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Basing, stage 1 of 4, 2 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 54.

Readings, end-of-day Oct 26, 2026
RSI (14)Neutral54.43
MACD / signalBelow signal line0.07 / 0.08, caution reading
SMA 50Price above1.26, favorable reading
SMA 200Price below2.52, caution reading
EMA 20Price above1.45, favorable reading
ADX (14)Firming23.53
Show all 12 readings
+DI / −DI+DI leading23.61 / 15.90, favorable reading
ATR (14)12.1% of price — elevated daily swings0.18, flagged reading
Stochastic %KMid-range43.31
Bollinger bands (20)Inside bands1.03 – 1.85
ROC (10)Negative over 10 sessions-18.82, caution reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis

What unlocking ADCT reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when ADCT's analysis runs, rather than checked against its stored data now.

Every section above, argued on ADCT's own numbers, on one page.

See what ADCT costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full ADCT analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get ADCT + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does ADC Therapeutics SA report earnings?

ADC Therapeutics SA (ADCT) is scheduled to report earnings on Nov 10, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock ADCT